Formulary drug reviews: Prothrombin complex concentrate

Hospital Pharmacy

Volumn 48, Issue 11, 2013, Pages 951-957

  Cada, Dennis J ^a   Levien, Terri L ^a   Baker, Danial E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CITRATE SODIUM; DABIGATRAN; FRESH FROZEN PLASMA; HEMOGLOBIN; HEPARIN; HUMAN ALBUMIN; HYDROCHLORIC ACID; PLACEBO; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN COMPLEX; RIVAROXABAN; SODIUM CHLORIDE; SODIUM HYDROXIDE; WARFARIN;

ABNORMAL RESPIRATORY SOUND; ACUTE DISEASE; ANEMIA; ANGIONEUROTIC EDEMA; ANTICOAGULANT THERAPY; ANTICOAGULATION; ANXIETY; ARTHRALGIA; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION REACTION; BRAIN HEMORRHAGE; BRONCHOSPASM; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTUSION; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG ANTAGONISM; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULARY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG LABELING; DRUG POTENCY; DRUG SAFETY; DRUG UTILIZATION; DYSPNEA; ERYTHROCYTE TRANSFUSION; FLUSHING; FOOD AND DRUG ADMINISTRATION; HEMATOMA; HEMOSTASIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; HYPOXIA; INSOMNIA; INTERNATIONAL NORMALIZED RATIO; LACERATION; LUNG EDEMA; LUNG EMBOLISM; MAXIMUM PERMISSIBLE DOSE; MEAN RESIDENCE TIME; MENTAL HEALTH; NAUSEA; PLASMA TRANSFUSION; RESPIRATORY DISTRESS; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SUBCUTANEOUS HEMORRHAGE; TACHYCARDIA; TACHYPNEA; THORAX PAIN; THROMBOEMBOLISM; URTICARIA; VOMITING; WHEEZING;

EID: 84890356535     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4811-951     Document Type: Review

References (20)

1. Kcentra [package insert]. Kankakee, IL: CSL Behring LLC; April 2013.
2. Ageno W, Gallus AS, Wittkowsky A, Growther M, Hylek EM, Palareti G. Oral anticoagulant therapy, antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2)(Suppl):e44S-e88S.
3. Factor IX Complex. Drug Facts and Comparisons. Facts & Comparisons [database online]. St. Louis, MO: Wolters Kluwer Health Inc; 2013. Accessed May 17, 2013.
4. Ogawa S, Szlam F, Ohnishi T, Molinaro RJ, Hosokawa K, Tanaka KA. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost. 2011; 106(6): 1215-1223.
5. Voils SA, Baird B. Systematic review: 3-factor versus 4- factor prothrombin complex concentrate for warfarin reversal: Does it matter? Thrombosis Res. 2012;130(6): 833-840.
6. Pragst I, Zeitler SH, Doerr B, et al. Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model. J Thromb Haemost. 2012;10(9): 1841-1848.
7. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate. A randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124(14): 1573-1579.
8. Kaatz S, Kouides PA, Garcia DA, et al. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol. 2012;87(Suppl 1):S141-S145.
9. Dinkelaar J, Molenaar PJ, Ninivaggi M, de Laat B, Brinkman HJ, Leyte A. In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for rivaroxaban [published online ahead of print April 11, 2013]. J Thromb Haemost. doi: 10.1111/jth.12236.
10. Lambourne MD, Eltringham-Smith LJ, Gataiance S, Arnold DM, Crowther MA, Sheffield WP. Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. J Thromb Haemost. 2012;10(9): 1830-1840.
11. Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: A randomised crossover ex vivo study in healthy volunteers. Thromb Haemost. 2012;108(2): 217-224.
12. Ostermann H, Haertel S, Knaub S, Kalina U, Jung K, Pabinger I. Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost. 2007;98(4): 790-797. (Pubitemid 47555071)
13. Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulation therapy, antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e152S-e184S.
14. Efficacy and safety study of Beriplex P/N compared with plasma in patients with acute major bleeding caused by anticoagulant therapy. ClinicalTrials.gov Web site. http://clinical trials.gov/ct2/show/NCT00708435. Updated April 3, 2012. Accessed May 17, 2013.
15. An open-label, randomized, multicenter phase IIIb study to assess the efficacy, safety and tolerance of Beriplex P/N compared with plasma for rapid reversal of coagulopathy induced by vitamin K antagonists in subjects requiring an urgent surgical procedure (BE1116-3003). ClinicalTrials.gov Web site. http://clinicaltrials.gov/ct2/show/NCT00803101?term=An+ openlabel%2C+randomized%2C+multicenter+phase+IIIb+study+ to+assess+the+efficacy%2C+safety+and+tolerance+of+Beriplex &rank=1. Updated March 26, 2013. Accessed May 17, 2013.
16. Pabinger I, Brenner B, Kalina U, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: A prospective multinational clinical trial. J Thromb Haemost. 2008;6(4): 622-631. (Pubitemid 351404929)
17. Preston FE, Laidlaw ST, Sampson B, Kitchen S. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): Efficacy and safety in 42 patients. Br J Haematol. 2012;116: 619-624.
18. Evans G, Luddington R, Baglin T. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol. 2001;115(4): 998-1001. (Pubitemid 34042922)
19. Hanke AA, Joch C, Gorlinger K. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): A pharmacovigilance study. Br J Anaesth. 2013;110(5): 764-772.
20. Cohen MR, Smetzer JL. ISMP medication error report analysis: Confusion with PCC orders. Hosp Pharm. 2013; 48(11):892-893,898.